On Thursday, San Francisco-based R&D cloud software company Benchling announced that it has acquired Belfast-based Ovewatch Research, a software company for customers working on preclinical biopharma ...
Benchling, a biotech company out of Y Combinator providing cloud-based software for researchers, tells TechCrunch it has raised $7 million in growth funding to continue creating tools to help the ...
In a field where the laboratory notebook is still considered the state of the art, it’s no wonder a company like Benchling, which provides software for managing life sciences research, was able to nab ...
Sajith Wickramasekara, Benchling’s CEO and co-founder. Eight months after enabling its R&D cloud to support FDA-regulated work done in later stages of biopharma product development, Benchling has ...
April 21 (Reuters) - Benchling, which develops software tools for scientists and pharmaceutical research organizations, has laid off 74 employees, or 9% of its workforce, its spokesperson confirmed on ...
Benchling, which makes cloud R&D software for life sciences companies, boomed during the pandemic. It just hit 1000 customers and hired new execs from companies like Atlassian, Workday, and Zendesk.
Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...
Y Combinator alum Benchling has raised $7 million to advance its cloud electronic lab notebook (ELN) and CRISPR design software, TechCrunch reports. Thrive Capital led the round with support from a ...
Benchling, the leading life sciences R&D cloud platform, today announced the launch of Benchling for Lab Automation, a new solution to help life sciences companies maximize lab automation investments.
More than ten years ago, I stopped using paper notebooks for my writing and consulting work. As someone who writes and thinks for a living, this was a big transition. But what a payoff I received in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results